Turmeric supplement boosts sleep in Alzheimer’s patients
Experts are finding turmeric supplements may help relieve memory loss in people with Alzheimer’s disease.
The supplement, named Elderberry, has been approved for use by the Food and Drug Administration for use in people over the age of 65.
The company’s website states Elderberry has been proven to boost cognitive function in Alzheimer patients.
It was first approved for Alzheimer’s treatment in 2011.
The FDA’s approval comes with limitations, however, such as its lack of an official FDA-approved dose of the supplement.
Dr. David Zatz, a senior physician at Brigham and Women’s Hospital in Boston, Massachusetts, who has studied the supplement, told ABC News it’s not clear yet if Elderberry supplements have a role in treating Alzheimer’s.
Zatz said he has seen some evidence Elderberry can improve sleep, but the study did not specifically compare the supplements with a placebo.
“The data that we’re looking at are not yet consistent, and it’s possible the effects are not quite the same,” he said.
“But it seems like the combination of Elderberry and the sleep enhancing properties is a pretty strong combination.”
Researchers are hopeful Elderberry’s potential for reducing memory loss could prove useful in treating the disease.
“One of the things we’ve found with Alzheimer patients is they can go into dementia and have some of the symptoms of Alzheimer’s, but they can’t function, can’t walk, can barely interact with the environment,” said Zatz.
“They have to rely on others to make it through.
So the benefits are, if we can provide some of those benefits, it’s a great opportunity to slow down the progression of Alzheimer disease.”
Dr. Christopher J. Pank, an associate professor of medicine at the University of Illinois at Chicago, said he’s seen evidence that Elderberry might help treat Alzheimer’s symptoms.
“There’s a number of studies that suggest that Elderberries can increase cognition and decrease symptoms of dementia,” Pank told ABCNews.com.
“I haven’t looked into the mechanisms yet, but I think that we are looking at a pretty big change in the brain.”